Literature DB >> 11071797

Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study.

G F Diercks1, A J van Boven, H L Hillege, W M Janssen, J A Kors, P E de Jong, D E Grobbee, H J Crijns, W H van Gilst.   

Abstract

AIM: To assess the value of microalbuminuria as an indicator of increased cardiovascular risk in a non-diabetic population. METHODS AND
RESULTS: 7579 non-diabetic subjects were studied with ages ranging from 28 to 75 years selected from a population based cohort. Using computerized Minnesota coding, ischaemic electrocardiographic abnormalities were divided into three categories: infarct patterns, major ischaemia, and minor ischaemia. Urinary albumin excretion was measured as the mean of two 24-h urine collections. Cardiovascular risk indicators were defined as an age above 60 years, male sex, hypertension, hypercholesterolaemia, smoking, obesity and a positive cardiovascular family history. Microalbuminuria was associated with age, sex, blood pressure, serum cholesterol, serum glucose, body mass index and all three categories of electrocardiographic abnormalities. In a multivariate model, adjusted for established cardiovascular risk indicators, microalbuminuria was independently associated with infarct patterns (OR [95% CI] 1.61 [1.12-2.32]), major ischaemia (OR 1.43 [1.08-1.91]) and minor ischaemia (OR 1.32 [1.03-1.68]).
CONCLUSIONS: The independent association between microalbuminuria and ischaemic electrocardiographic abnormalities suggests that microalbuminuria has additional value to conventional risk indicators in predicting cardiovascular disease in non-diabetics. Assessment of microalbuminuria could be an instrument to identify those at an increased risk for coronary vascular disease in an early stage. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2000        PMID: 11071797     DOI: 10.1053/euhj.2000.2248

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  30 in total

1.  Sex differences in new-onset heart failure.

Authors:  Sven Meyer; Frank P Brouwers; Adriaan A Voors; Hans L Hillege; Rudolf A de Boer; Ron T Gansevoort; Pim van der Harst; Michiel Rienstra; Isabelle C van Gelder; Dirk J van Veldhuisen; Wiek H van Gilst; Peter van der Meer
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

2.  [Tackling lipaemia in diabetes mellitus in primary care].

Authors:  C Llor Vilà
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

Review 3.  Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.

Authors:  Valentina Kon; Haichun Yang; Sergio Fazio
Journal:  Arch Med Res       Date:  2015-05-23       Impact factor: 2.235

4.  Prevalence of microalbuminuria among secondary school children.

Authors:  A N Okpere; I C Anochie; F U Eke
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

Review 5.  Impact of microalbuminuria on incident coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis of prospective studies.

Authors:  Fang Xia; Guanghua Liu; Yifu Shi; Yan Zhang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

6.  Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study.

Authors:  Yit-Sheung Yap; Wen-Che Chi; Cheng-Hao Lin; Yi-Wen Wu; Yi-Chun Liu
Journal:  Int Urol Nephrol       Date:  2012-03-31       Impact factor: 2.370

Review 7.  Microalbuminuria in hypertension.

Authors:  Paolo Palatini
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

8.  Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.

Authors:  Mohamed E Suliman; Mahmut I Yilmaz; Juan J Carrero; Abdul Rashid Qureshi; Mutlu Saglam; Osman M Ipcioglu; Mujdat Yenicesu; Mengli Tong; Olof Heimbürger; Peter Barany; Anders Alvestrand; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 8.237

9.  The role of microalbuminuria as a predictor of subclinical cardiovascular events in rheumatoid arthritis patients and its relation to disease activity.

Authors:  D W Nada; S El Morsy; M H Abu-Zaid; M A Aboelhawa; Mohammad A Zakaria; E A El Sheikh; R A Gaber
Journal:  Clin Rheumatol       Date:  2017-10-23       Impact factor: 2.980

10.  Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men>40 years of age (from the Rancho Bernardo Study).

Authors:  Simerjot Kaur Jassal; Claudia Langenberg; Denise von Mühlen; Jaclyn Bergstrom; Elizabeth Barrett-Connor
Journal:  Am J Cardiol       Date:  2008-03-07       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.